검색
Sophia Genetics SA
SOPH관심 목록에 추가
5.350USD
-0.240-4.29%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
384.08M시가총액
손실P/E TTM
자세한 내용은 Sophia Genetics SA 회사
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA 정보
종목 코드 SOPH
회사 이름SOPHiA GENETICS SA
상장일Jul 23, 2021
CEOCamblong (Jurgi)
직원 수423
유형Ordinary Share
회계 연도 종료Jul 23
주소La Piece 12
도시ROLLE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Switzerland
우편 번호CH-1180
전화41216941060
웹사이트https://www.sophiagenetics.com/
종목 코드 SOPH
상장일Jul 23, 2021
CEOCamblong (Jurgi)
Sophia Genetics SA의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.98M
-0.94%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
625.61K
-0.07%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
509.18K
-0.79%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
217.28K
+8.85%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
204.44K
+9.65%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
128.68K
-7.77%
Mr. Daan Van Well
Mr. Daan Van Well
Chief Legal and Compliance Officer
Chief Legal and Compliance Officer
--
--
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.98M
-0.94%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
625.61K
-0.07%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
509.18K
-0.79%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
217.28K
+8.85%
자주 묻는 질문
Sophia Genetics SA의 상위 5대 주주는 누구인가요?
Sophia Genetics SA의 상위 5대 주주는 다음과 같습니다: Dr. Jurgi Camblong, Ph.D.
Sophia Genetics SA(SOPH)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Sophia Genetics SA의 주식을 보유한 기관은 총 89곳이며, 이들이 보유한 주식의 총 가치는 약 27.73M로 전체 발행 주식의 38.63%를 차지합니다. 이는 2025Q4 대비 -11894064.00 증가한 수치입니다.